SCHEMBL9211331

SCHEMBL9211331

CCCCc1ncc(CCN[C@@H](CCc2ccccc2)C(=O)O)n1Cc1ccccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9211338 1.00
SCHEMBL9206267 0.93
SCHEMBL9206268 0.93
SCHEMBL9209633 0.92 AGTR1 (0.56)
SCHEMBL9209632 0.92 AGTR1 (0.56)
SCHEMBL9214275 0.87
SCHEMBL9214266 0.87
SCHEMBL9208575 0.85 AGTR1 (0.58)
SCHEMBL7432919 0.85 AGTR1 (0.60)
SCHEMBL7432923 0.85 AGTR1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0427463-B1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORP (US) 1995-03-08 EP disclosed
US-5248689-A Hypotensive agents, congestive heart failure, renal failure or glaucoma SMITHKLINE BEECHAM CORPORATION (US) 1993-09-28 US disclosed
EP-0427463-A1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORPORATION (US) 1991-05-15 EP disclosed